The prognosis for AML can vary widely depending on several factors, including the patient's age, overall health, and specific genetic mutations of the leukemia cells. While younger patients and those with certain favorable genetic markers tend to have better outcomes, the overall prognosis for AML remains challenging and requires intensive treatment.